Study of ALN-4324 on Insulin Sensitivity in Type 2 Diabetes
Part of Hormones & metabolism clinical trials.
This study tests an experimental drug, ALN-4324, to see if it can improve how your body responds to insulin. It’s for adults with type 2 diabetes who are already on certain diabetes medications and have stable blood sugar control.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have type 2 diabetes and are 18 years or older.
- Your BMI is between 23 and 39.9.
- Your most recent A1C is between 6.5% and 10.4%.
- You are taking a stable dose of metformin, an SGLT2 inhibitor, or a DPP-4 inhibitor for your diabetes.
- You do not have any other serious medical conditions or take other medicines that affect blood sugar (except birth control).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-stage study tests a new experimental drug (NNC0487-0111) designed to help regulate insulin levels in adults with type 2 diabetes. Researchers want to see if it works safely and effectively when combined with your current diabetes medications.
This study tests a new medication to see if it can improve how your body responds to insulin and boost your cells' energy (mitochondrial function). It is for adults with type 1 diabetes who are already on insulin and have good overall health.
This study tests an experimental tablet to see if it can help control blood sugar in people with type 2 diabetes. It may be an option for those who are already on metformin or managing with diet and exercise.
This study is testing a new injectable medication (IN-B00009) to see if it helps lower blood sugar in people with type 2 diabetes who are not currently on diabetes medicine. It might be an option if diet and exercise alone are not enough to control your diabetes.
This Phase 3 study tests whether LID104 can improve blood sugar control and safety in people with type 2 diabetes who are not meeting their A1c goal on metformin. You may benefit if your diabetes is still too high despite diet, exercise, and the usual metformin dose.
This trial tests how stopping a type 2 diabetes medication called an SGLT2 inhibitor affects the liver's production of sugar and ketones. It may help understand better ways to manage diabetes.
Hear when a new Type 2 Diabetes Mellitus (T2DM) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.